RAWALPINDI — Pharmaceutical traders in Rawalpindi have expressed their approval of the federal budget for fiscal year 2026-27. They highlight significant relief measures concerning medicines and taxation.
Excise Duty Abolition
The government’s decision to abolish Federal Excise Duty (FED) on essential medicines, especially those crucial for treating severe diseases like cancer, has been praised by the sector.
Impact on Patients
Faizan Malik, a local trader, emphasized that this move will ease financial burdens on patients while improving access to necessary medications. These relief measures are likely to aid pharmacy traders by enhancing both affordability and demand for medicines.
Taxation Stability for Pharmaceuticals
Malik also noted the positive consequences of maintaining stable taxation policies in the pharmaceutical sector. He stressed that this stability is vital for ensuring a continuous supply and fair pricing of medicines.
Pro-Public Budget Focus
Another trader, Khurram, echoed these views, commending the budget’s pro-public focus, particularly in the health sector. He pointed out that removing FED on critical medications will directly benefit patients with life-threatening conditions, reducing healthcare costs.
Khurram also underscored the need for ongoing support and consistent policy implementation to enhance the healthcare supply chain.
